Is Seprafilm valuable in infant cardiac redo procedures?

J Cardiothorac Surg. 2015 Mar 31:10:47. doi: 10.1186/s13019-015-0257-2.

Abstract

Background: Morbidity and mortality are higher for cardiac reoperations than first operation due to the presence of post-operative adhesions. We retrospectively evaluated the efficacy of the bioresorbable membrane Seprafilm to prevent pericardial adhesions after cardiac surgery in a paediatric congenital heart disease population.

Methods: Seventy-one children undergoing reoperations with sternotomy redo and cardiopulmonary bypass for congenital malformations were included. Twenty-nine of these patients were reoperated after previous application of Seprafilm (treatment group). The duration of dissection, aortic cross clamping and total surgery were recorded. A tenacity score was established for each intervention from the surgeon's description in the operating report.

Results: In multivariate analysis, the duration of dissection and the tenacity score were lower in the treatment than control group (p < 0.01), independent of age and interval since preceding surgery.

Conclusion: Our results suggest that Seprafilm is effective in reducing the post-operative adhesions associated with infant cardiac surgery. We recommend the use of Seprafilm in paediatric cardiac surgery when staged surgical interventions are necessary.

Publication types

  • Evaluation Study

MeSH terms

  • Cardiopulmonary Bypass
  • Female
  • Heart Defects, Congenital / surgery*
  • Humans
  • Hyaluronic Acid*
  • Infant
  • Male
  • Multivariate Analysis
  • Pericardium / surgery
  • Postoperative Complications / prevention & control*
  • Reoperation
  • Retrospective Studies
  • Sternotomy
  • Tissue Adhesions / etiology
  • Tissue Adhesions / prevention & control*

Substances

  • Seprafilm
  • Hyaluronic Acid